<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35543837</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1435-4373</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>11</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</Title>
          <ISOAbbreviation>Eur J Clin Microbiol Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10096-022-04453-0</ELocationID>
        <Abstract>
          <AbstractText>We described the population structure of Bordetella pertussis (B. pertussis) in Norway from 1996 to 2019 and determined if there were evolutionary shifts and whether these correlated with changes in the childhood immunization program. We selected 180 B. pertussis isolates, 22 from the whole cell vaccine (WCV) era (1996-1997) and 158 from the acellular vaccine (ACV) era (1998-2019). We conducted whole genome sequencing and determined the distribution and frequency of allelic variants and temporal changes of ACV genes. Norwegian B. pertussis isolates were evenly distributed across a phylogenetic tree that included global strains. We identified seven different allelic profiles of ACV genes (A-F), in which profiles A1, A2, and B dominated (89%), all having pertussis toxin (ptxA) allele 1, pertussis toxin promoter (ptxP) allele 3, and pertactin (prn) allele 2 present. Isolates with ptxP1 and prn1 were not detected after 2007, whereas the prn2 allele likely emerged prior to 1972, and ptxP3 before the early 1980s. Allele conversions of ACV genes all occurred prior to the introduction of ACV. Sixteen percent of our isolates showed mutations within the prn gene. ACV and its booster doses (implemented for children in 2007 and adolescents in 2013) might have contributed to evolvement of a more uniform B. pertussis population, with recent circulating strains having ptxA1, ptxP3, and prn2 present, and an increasing number of prn mutations. These strains clearly deviate from ACV strains (ptxA1, ptxP1, prn1), and this could have implications for vaccine efficiency and, therefore, prevention and control of pertussis.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Brandal</LastName>
            <ForeName>Lin T</ForeName>
            <Initials>LT</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway. lin.thorstensen.brandal@fhi.no.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>European Program for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. lin.thorstensen.brandal@fhi.no.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vestrheim</LastName>
            <ForeName>Didrik F</ForeName>
            <Initials>DF</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bruvik</LastName>
            <ForeName>Torbjørn</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roness</LastName>
            <ForeName>Ragnhild B</ForeName>
            <Initials>RB</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bjørnstad</LastName>
            <ForeName>Martha L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Greve-Isdahl</LastName>
            <ForeName>Margrethe</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Steens</LastName>
            <ForeName>Anneke</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brynildsrud</LastName>
            <ForeName>Ola B</ForeName>
            <Initials>OB</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Norwegian University of Life Sciences, Ås, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA>
        <NlmUniqueID>8804297</NlmUniqueID>
        <ISSNLinking>0934-9723</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bordetella pertussis</Keyword>
        <Keyword MajorTopicYN="N">Evolution</Keyword>
        <Keyword MajorTopicYN="N">Genomic variation</Keyword>
        <Keyword MajorTopicYN="N">Vaccine-related antigens</Keyword>
        <Keyword MajorTopicYN="N">Whole genome sequencing</Keyword>
        <Keyword MajorTopicYN="N">Whooping cough</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>11</Hour>
          <Minute>18</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35543837</ArticleId>
        <ArticleId IdType="doi">10.1007/s10096-022-04453-0</ArticleId>
        <ArticleId IdType="pii">10.1007/s10096-022-04453-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>World Health Organization (2015) Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 90(35):433–458</Citation>
        </Reference>
        <Reference>
          <Citation>Barkoff AM, He Q (2019) Molecular epidemiology of Bordetella pertussis. Adv Exp Med Biol https://doi.org/10.1007/5584_2019_402</Citation>
        </Reference>
        <Reference>
          <Citation>Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW (2017) An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis 17(9):974–980. https://doi.org/10.1016/s1473-3099(17)30390-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1473-3099(17)30390-0</ArticleId>
            <ArticleId IdType="pubmed">28623146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>European Centre for Disease Prevention and Control (2020) Pertussis. In: ECDC. Annual Epidemiological Report for 2018. Stockholm, ECDC.</Citation>
        </Reference>
        <Reference>
          <Citation>European Centre for Disease Prevention and Control (2019) Pertussis. Annual Epidemiological Report for 2017. Stockholm, ECDC</Citation>
        </Reference>
        <Reference>
          <Citation>Zeddeman A, Witteveen S, Bart MJ, van Gent M, van der Heide HG, Heuvelman KJ et al (2015) Studying Bordetella pertussis populations by use of SNPeX, a simple high-throughput single nucleotide polymorphism typing method. J Clin Microbiol 53(3):838–846. https://doi.org/10.1128/jcm.02995-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jcm.02995-14</ArticleId>
            <ArticleId IdType="pubmed">25568442</ArticleId>
            <ArticleId IdType="pmc">4390674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavine JS, Bjornstad ON, de Blasio BF, Storsaeter J (2012) Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 30(3):544–551. https://doi.org/10.1016/j.vaccine.2011.11.065</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2011.11.065</ArticleId>
            <ArticleId IdType="pubmed">22119924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stefanelli P (2019) Pertussis: identification, prevention and control. Adv Exp Med Biol 1183:127–36. https://doi.org/10.1007/5584_2019_408</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/5584_2019_408</ArticleId>
            <ArticleId IdType="pubmed">31321754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>European Centre for Disease Prevention and Control (2019) External quality assessment for the detection of Bordetella pertussis by PCR, 2018 – on behalf of EUPert-LabNet network. Stockholm, ECDC</Citation>
        </Reference>
        <Reference>
          <Citation>Cherry JD (2005) The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 115(5):1422–1427. https://doi.org/10.1542/peds.2004-2648</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2004-2648</ArticleId>
            <ArticleId IdType="pubmed">15867059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J et al (2011) Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 11(7):557–570. https://doi.org/10.1016/s1473-3099(11)70007-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1473-3099(11)70007-x</ArticleId>
            <ArticleId IdType="pubmed">21600850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P et al (2019) Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines. Front Immunol 10:1344. https://doi.org/10.3389/fimmu.2019.01344</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2019.01344</ArticleId>
            <ArticleId IdType="pubmed">31333640</ArticleId>
            <ArticleId IdType="pmc">6616129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wendelboe AM, Van Rie A, Salmaso S, Englund JA (2005) Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 24(5 Suppl):S58-61. https://doi.org/10.1097/01.inf.0000160914.59160.41</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.inf.0000160914.59160.41</ArticleId>
            <ArticleId IdType="pubmed">15876927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guiso N, Njamkepo E, Vié le Sage F, Zepp F, Meyer CU, Abitbol V et al (2007) Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine 25(8):1390–7. https://doi.org/10.1016/j.vaccine.2006.10.048</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2006.10.048</ArticleId>
            <ArticleId IdType="pubmed">17134795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mooi FR, Van Der Maas NA, De Melker HE (2014) Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol Infect 142(4):685–694. https://doi.org/10.1017/s0950268813000071</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/s0950268813000071</ArticleId>
            <ArticleId IdType="pubmed">23406868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S et al (2019) Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Euro Surveill: Bull Europeen sur les maladies transmissibles = Eur Commun Dis Bull 24(7) https://doi.org/10.2807/1560-7917.Es.2019.24.7.1700832 .</Citation>
        </Reference>
        <Reference>
          <Citation>Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V et al (2014) Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. mBio 5(2):e01074. https://doi.org/10.1128/mBio.01074-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.01074-14</ArticleId>
            <ArticleId IdType="pubmed">24757216</ArticleId>
            <ArticleId IdType="pmc">3994516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Gent M, Heuvelman CJ, van der Heide HG, Hallander HO, Advani A, Guiso N et al (2015) Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998–2012. Eur J Clin Microbiol Infect Dis: Off Publ Eur Soc Clin Microbiol 34(4):821–830. https://doi.org/10.1007/s10096-014-2297-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-014-2297-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zomer A, Otsuka N, Hiramatsu Y, Kamachi K, Nishimura N, Ozaki T et al (2018) Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines. Microbial Genom 4(5); https://doi.org/10.1099/mgen.0.000180</Citation>
        </Reference>
        <Reference>
          <Citation>Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S et al (2018) Surveillance of circulating Bordetella pertussis strains in Europe during 1998 to 2015. J Clin Microbiol 56(5); https://doi.org/10.1128/jcm.01998-17</Citation>
        </Reference>
        <Reference>
          <Citation>Weigand MR, Williams MM, Peng Y, Kania D, Pawloski LC, Tondella ML (2019) Genomic survey of Bordetella pertussis diversity, United States, 2000–2013. Emerg Infect Dis 25(4):780–783. https://doi.org/10.3201/eid2504.180812</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2504.180812</ArticleId>
            <ArticleId IdType="pubmed">30882317</ArticleId>
            <ArticleId IdType="pmc">6433035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weigand MR, Pawloski LC, Peng Y, Ju H, Burroughs M, Cassiday PK et al (2018) Screening and genomic characterization of filamentous hemagglutinin-deficient Bordetella pertussis. Infect Immun 86(4); https://doi.org/10.1128/iai.00869-17</Citation>
        </Reference>
        <Reference>
          <Citation>van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Mooi FR (2012) Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS ONE 7(9):e46407. https://doi.org/10.1371/journal.pone.0046407</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0046407</ArticleId>
            <ArticleId IdType="pubmed">23029513</ArticleId>
            <ArticleId IdType="pmc">3460923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ et al (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15(8):1206–1213. https://doi.org/10.3201/eid1508.081511</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1508.081511</ArticleId>
            <ArticleId IdType="pubmed">19751581</ArticleId>
            <ArticleId IdType="pmc">2815961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y, Liu B, Grondahl-Yli-Hannuksila K, Tan Y, Feng L, Kallonen T et al (2015) Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis. Sci Rep 5:12888. https://doi.org/10.1038/srep12888</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep12888</ArticleId>
            <ArticleId IdType="pubmed">26283022</ArticleId>
            <ArticleId IdType="pmc">4539551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Octavia S, Maharjan RP, Sintchenko V, Stevenson G, Reeves PR, Gilbert GL et al (2011) Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. Mol Biol Evol 28(1):707–715. https://doi.org/10.1093/molbev/msq245</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/molbev/msq245</ArticleId>
            <ArticleId IdType="pubmed">20833694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seppälä E, Kristoffersen AB, Bøås H, Vestrheim DF, Greve-Isdahl M, De Blasio BF et al (2021) Pertussis epidemiology and indirect impact of the childhood pertussis booster vaccinations, Norway, 1998–2019. Abstract, ESCAIDE</Citation>
        </Reference>
        <Reference>
          <Citation>Zeddeman A, van Gent M, Heuvelman CJ, van der Heide HG, Bart MJ, Advani A et al (2014) Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill: Bull Europeen sur les maladies transmissibles = Eur Commun Dis Bull 19(33) https://doi.org/10.2807/1560-7917.es2014.19.33.20881 .</Citation>
        </Reference>
        <Reference>
          <Citation>Khelef N, Danve B, Quentin-Millet MJ, Guiso N (1993) Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun 61(2):486–490. https://doi.org/10.1128/iai.61.2.486-490.1993</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.61.2.486-490.1993</ArticleId>
            <ArticleId IdType="pubmed">8423077</ArticleId>
            <ArticleId IdType="pmc">302754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR (2005) Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathogens 1(4):e45. https://doi.org/10.1371/journal.ppat.0010045</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.0010045</ArticleId>
            <ArticleId IdType="pubmed">16389302</ArticleId>
            <ArticleId IdType="pmc">1323478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar S, Stecher G, Li M, Knyaz C, Tamura K (2018) MEGA X: Molecular Evolutionary Genetics Analysis across computing platforms. Mol Biol Evol 35(6):1547–1549. https://doi.org/10.1093/molbev/msy096</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/molbev/msy096</ArticleId>
            <ArticleId IdType="pubmed">29722887</ArticleId>
            <ArticleId IdType="pmc">5967553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao K, Deng J, Ma X, Dai W, Chen Q, Zhou K et al (2020) The epidemic of erythromycin-resistant Bordetella pertussis with limited genome variation associated with pertussis resurgence in China. Expert Rev Vaccines 19(11):1093–9. https://doi.org/10.1080/14760584.2020.1831916</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14760584.2020.1831916</ArticleId>
            <ArticleId IdType="pubmed">33034224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Letunic I, Bork P (2019) Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucleic Acids Res 47(W1):W256–W259. https://doi.org/10.1093/nar/gkz239</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkz239</ArticleId>
            <ArticleId IdType="pubmed">30931475</ArticleId>
            <ArticleId IdType="pmc">6602468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE (2005) Resurgence of pertussis in Europe. Pediatr Infect Dis J 24(9):761–765. https://doi.org/10.1097/01.inf.0000177282.53500.77</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.inf.0000177282.53500.77</ArticleId>
            <ArticleId IdType="pubmed">16148840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ntezayabo B, De Serres G, Duval B (2003) Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J 22(1):22–27. https://doi.org/10.1097/00006454-200301000-00009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006454-200301000-00009</ArticleId>
            <ArticleId IdType="pubmed">12544404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Safarchi A, Octavia S, Wu SZ, Kaur S, Sintchenko V, Gilbert GL et al (2016) Genomic dissection of Australian Bordetella pertussis isolates from the 2008–2012 epidemic. J Infect 72(4):468–477. https://doi.org/10.1016/j.jinf.2016.01.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2016.01.005</ArticleId>
            <ArticleId IdType="pubmed">26826518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefrancq N, Bouchez V, Fernandes N, Barkoff A-M, Bosch T, Dalby T et al (2021) Spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis.</Citation>
        </Reference>
        <Reference>
          <Citation>Bouchez V, Guillot S, Landier A, Armatys N, Matczak S, group tFpms et al (2021) Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018. Eurosurveillance 26(37):2001213; https://doi.org/10.2807/1560-7917.ES.2021.26.37.2001213 .</Citation>
        </Reference>
        <Reference>
          <Citation>Clarke M, McIntyre PB, Blyth CC, Wood N, Octavia S, Sintchenko V et al (2016) The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. J Infect 72(2):171–178. https://doi.org/10.1016/j.jinf.2015.11.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2015.11.004</ArticleId>
            <ArticleId IdType="pubmed">26675318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Z, Wang Z, Luan Y, Li Y, Liu X, Peng X et al (2019) Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China. Emerg Microbes Infect 8(1):461–70. https://doi.org/10.1080/22221751.2019.1587315</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/22221751.2019.1587315</ArticleId>
            <ArticleId IdType="pubmed">30898080</ArticleId>
            <ArticleId IdType="pmc">6455148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alai S, Ghattargi VC, Gautam M, Patel K, Pawar SP, Dhotre DP et al (2020) Comparative genomics of whole-cell pertussis vaccine strains from India. BMC Genomics 21(1):345. https://doi.org/10.1186/s12864-020-6724-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12864-020-6724-8</ArticleId>
            <ArticleId IdType="pubmed">32381023</ArticleId>
            <ArticleId IdType="pmc">7204287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Safarchi A, Saedi S, Octavia S, Sedaghatpour M, Bolourchi N, Tay CY et al (2021) Evolutionary genomics of recent clinical Bordetella pertussis isolates from Iran: wide circulation of multiple ptxP3 lineages and report of the first ptxP3 filamentous hemagglutinin-negative B. pertussis. Infect Genet Evol: J Mol Epidemiol Evol Genet Infect Dis 93:104970. https://doi.org/10.1016/j.meegid.2021.104970</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.meegid.2021.104970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidtke A, Boney K, Martin S, Skoff T, Tondella ML, Tatti K (2012) Population diversity among Bordetella pertussis isolates, United States, 1935–2009. Emerg Infect Dis J 18(8):1248. https://doi.org/10.3201/eid1808.120082</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1808.120082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ring N, Abrahams JS, Bagby S, Preston A, MacArthur I (2019) How genomics is changing what we know about the evolution and genome of Bordetella pertussis. Adv Exp Med Biol 1183:1–17. https://doi.org/10.1007/5584_2019_401</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/5584_2019_401</ArticleId>
            <ArticleId IdType="pubmed">31321755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma L, Caulfield A, Dewan K, Harvill E (2021) Pertactin-deficient Bordetella pertussis, vaccine-driven evolution, and reemergence of pertussis. Emerg Infect Dis J 27(6):1561. https://doi.org/10.3201/eid2706.203850</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2706.203850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Safarchi A, Octavia S, Nikbin VS, Lotfi MN, Zahraei SM, Tay CY et al (2019) Genomic epidemiology of Iranian Bordetella pertussis: 50 years after the implementation of whole cell vaccine. Emerg Microbes Infect 8(1):1416–27. https://doi.org/10.1080/22221751.2019.1665479</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/22221751.2019.1665479</ArticleId>
            <ArticleId IdType="pubmed">31543006</ArticleId>
            <ArticleId IdType="pmc">6764348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiramatsu Y, Miyaji Y, Otsuka N, Arakawa Y, Shibayama K, Kamachi K (2017) Significant decrease in pertactin-deficient Bordetella pertussis isolates, Japan. Emerg Infect Dis J 23(4):699. https://doi.org/10.3201/eid2304.161575</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2304.161575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otsuka N, Han H-J, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y, Shibayama K et al (2012) Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS ONE 7(2):e31985. https://doi.org/10.1371/journal.pone.0031985</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0031985</ArticleId>
            <ArticleId IdType="pubmed">22348138</ArticleId>
            <ArticleId IdType="pmc">3279416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Locht C, Carbonetti NH, Cherry JD, Damron FH, Edwards KM, Fernandez R et al (2020) Highlights of the 12th International Bordetella Symposium. Clin Infect Dis: Off Publ Infect Dis Soc Am 71(9):2521–2526. https://doi.org/10.1093/cid/ciaa651</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciaa651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorji D, Mooi F, Yantorno O, Deora R, Graham RM, Mukkur TK (2018) Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Med Microbiol Immunol 207(1):3–26. https://doi.org/10.1007/s00430-017-0524-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00430-017-0524-z</ArticleId>
            <ArticleId IdType="pubmed">29164393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowden KE, Weigand MR, Peng Y, Cassiday PK, Sammons S, Knipe K et al (2016) Genome structural diversity among 31 Bordetella pertussis isolates from two recent U.S. whooping cough statewide epidemics. mSphere 1(3) https://doi.org/10.1128/mSphere.00036-16</Citation>
        </Reference>
        <Reference>
          <Citation>Weigand MR, Peng Y, Loparev V, Batra D, Bowden KE, Burroughs M et al (2017) The history of Bordetella pertussis genome evolution includes structural rearrangement. J Bacteriol 199(8); https://doi.org/10.1128/jb.00806-16</Citation>
        </Reference>
        <Reference>
          <Citation>Ring N, Abrahams JS, Jain M, Olsen H, Preston A, Bagby S (2018) Resolving the complex Bordetella pertussis genome using barcoded nanopore sequencing. Microbial Genomics 4(11):e000234. https://doi.org/10.1099/mgen.0.000234</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mgen.0.000234</ArticleId>
            <ArticleId IdType="pmc">6321869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouchez V, Brun D, Dore G, Njamkepo E, Guiso N (2011) Bordetella parapertussis isolates not expressing pertactin circulating in France. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis 17(5):675–682. https://doi.org/10.1111/j.1469-0691.2010.03303.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2010.03303.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q (2012) Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol 19(10):1703–1704. https://doi.org/10.1128/cvi.00367-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/cvi.00367-12</ArticleId>
            <ArticleId IdType="pubmed">22914363</ArticleId>
            <ArticleId IdType="pmc">3485885</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
